HT
TPST icon

HAP Trading’s Tempest Therapeutics TPST Stock Holding History

HAP Trading’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-785
Closed -$270K – 1920
2020
Q2 		$270K Buy
+785
New +$313K 0.01% 607
2015
Q4 		– Sell
-12
Closed -$396K – 1109
2015
Q3 		$296K Buy
+12
New +$808K 0.02% 463

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HAP Trading's TPST Position: Q3 2020 in Review

HAP Trading sold out of Tempest Therapeutics (TPST) in Q3 2020, closing a stake of 785 shares — an estimated $270K sold.

HAP Trading first reported a position in TPST in Q3 2015 and held it in 2 quarters. The position peaked at $296K in Q3 2015. 42 funds tracked by Wall St. Rank hold TPST as of Q3 2020.

  • HAP Trading reported no remaining Tempest Therapeutics position as of Q3 2020 after selling out during the quarter.
  • HAP Trading sold 785 Tempest Therapeutics shares in Q3 2020, an estimated $270K.
  • HAP Trading first reported a position in Tempest Therapeutics in Q3 2015 and held it in 2 quarters.
  • HAP Trading's Tempest Therapeutics position peaked at $296K in Q3 2015.
  • 42 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2020.

Based on HAP Trading's 13F filing for Q3 2020, filed 13 Nov 2020.